Castle Biosciences, Inc. (CSTL)
33.79
-0.71
(-2.06%)
USD |
NASDAQ |
Nov 13, 16:00
33.77
-0.02
(-0.06%)
After-Hours: 19:59
Castle Biosciences Market Cap : 1.040B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.040B |
| November 12, 2026 | 1.062B |
| November 11, 2026 | 1.046B |
| November 10, 2026 | 1.059B |
| November 09, 2026 | 1.058B |
| November 06, 2026 | 1.001B |
| November 05, 2026 | 1.052B |
| November 04, 2026 | 1.100B |
| November 03, 2026 | 1.081B |
| November 02, 2026 | 1.066B |
| October 30, 2026 | 1.134B |
| October 29, 2026 | 1.175B |
| October 28, 2026 | 1.119B |
| October 27, 2026 | 1.053B |
| October 26, 2026 | 1.016B |
| October 23, 2026 | 1.009B |
| October 22, 2026 | 1.013B |
| October 21, 2026 | 1.049B |
| October 20, 2026 | 1.011B |
| October 19, 2026 | 981.31M |
| October 16, 2026 | 975.05M |
| October 15, 2026 | 1.031B |
| October 14, 2026 | 1.010B |
| October 13, 2026 | 1.003B |
| October 12, 2026 | 999.46M |
| Date | Value |
|---|---|
| October 09, 2026 | 1.050B |
| October 08, 2026 | 1.028B |
| October 07, 2026 | 1.007B |
| October 06, 2026 | 1.018B |
| October 05, 2026 | 1.118B |
| October 02, 2026 | 1.085B |
| October 01, 2026 | 1.076B |
| September 30, 2026 | 1.084B |
| September 29, 2026 | 1.064B |
| September 28, 2026 | 1.096B |
| September 25, 2026 | 1.093B |
| September 24, 2026 | 1.074B |
| September 23, 2026 | 1.064B |
| September 22, 2026 | 1.063B |
| September 21, 2026 | 1.067B |
| September 18, 2026 | 1.078B |
| September 17, 2026 | 1.122B |
| September 16, 2026 | 1.082B |
| September 15, 2026 | 1.083B |
| September 14, 2026 | 1.020B |
| September 11, 2026 | 986.34M |
| September 10, 2026 | 986.03M |
| September 09, 2026 | 985.73M |
| September 08, 2026 | 999.46M |
| September 04, 2026 | 1.004B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| RadNet, Inc. | 6.020B |
| Lumexa Imaging Holdings, Inc. | 1.423B |
| Quest Diagnostics, Inc. | 28.56B |
| Labcorp Holdings, Inc. | 30.08B |
| OPKO Health, Inc. | 1.196B |
Market Cap Related Metrics
| PS Ratio | 2.694 |
| PEG Ratio | -0.6254 |
| Price to Book Value | 2.173 |
| Price to Free Cash Flow | 256.33 |
| Price | 33.79 |
| Earnings Yield | -2.27% |
| PEGY Ratio | -0.6254 |